PEAK6 Investments LLC - SPDR SERIES TRUST ownership

SPDR SERIES TRUST's ticker is KRE and the CUSIP is 78464A698. A total of 512 filers reported holding SPDR SERIES TRUST in Q1 2023. The put-call ratio across all filers is 1.51 and the average weighting 0.4%.

Quarter-by-quarter ownership
PEAK6 Investments LLC ownership history of SPDR SERIES TRUST
ValueSharesWeighting
Q3 2023$36,089,572
-27.1%
864,007
-28.7%
0.17%
-26.2%
Q2 2023$49,500,985
-36.3%
1,212,368
-31.6%
0.22%
-39.7%
Q1 2023$77,713,078
+637.9%
1,771,844
+888.3%
0.37%
+511.5%
Q4 2022$10,531,436
-86.4%
179,289
-86.4%
0.06%
-81.2%
Q3 2022$77,563,000
-18.5%
1,317,300
-34.1%
0.32%
+78.0%
Q2 2022$95,216,985
+218.7%
1,999,368
+361.1%
0.18%
+184.4%
Q1 2022$29,873,000
+111.6%
433,578
+117.6%
0.06%
+113.3%
Q4 2021$14,120,000
-32.1%
199,300
-35.0%
0.03%
-36.2%
Q3 2021$20,786,000
+93.2%
306,800
+86.8%
0.05%
+88.0%
Q2 2021$10,760,000
-28.3%
164,200
-27.5%
0.02%
-30.6%
Q1 2021$15,017,000
+33.0%
226,356
+4.1%
0.04%
+50.0%
Q4 2020$11,290,000
-22.4%
217,337
-46.7%
0.02%
-33.3%
Q3 2020$14,555,000
-30.4%
407,939
-25.1%
0.04%
-50.7%
Q2 2020$20,907,000
+48.0%
544,574
+124.5%
0.07%
+1.4%
Q4 2019$14,128,000
+7.8%
242,532
-2.3%
0.07%
-12.2%
Q3 2019$13,102,000
-47.0%
248,200
-46.4%
0.08%
-50.0%
Q2 2019$24,730,000
+4.7%
462,848
+0.6%
0.16%
+18.0%
Q1 2019$23,624,000
-49.1%
460,157
-53.6%
0.14%
-52.9%
Q4 2018$46,410,000
+806.1%
991,864
+1050.7%
0.30%
+1240.9%
Q3 2018$5,122,00086,2000.02%
Other shareholders
SPDR SERIES TRUST shareholders Q1 2023
NameSharesValueWeighting ↓
Hefren-Tillotson, Inc. 1,775,216$73,103,00033.42%
XPONANCE, INC. 771,984$31,287,00012.10%
Yost Capital Management, LP 230,000$9,471,0009.10%
CHARTIST INC /CA/ 24,871$1,014,0006.21%
WOOSTER CORTHELL WEALTH MANAGEMENT, INC. 194,189$7,997,0006.00%
IRON Financial LLC 169,905$6,997,0004.66%
Verity Asset Management, Inc. 91,740$3,778,0003.78%
EnTrustPermal Management LLC 65,700$2,706,0003.29%
United Asset Strategies, Inc. 139,950$5,763,0002.66%
ELLIOTT MANAGEMENT CORP 2,950,000$121,540,0002.33%
View complete list of SPDR SERIES TRUST shareholders